780 related articles for article (PubMed ID: 22357833)
21. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780
[TBL] [Abstract][Full Text] [Related]
22. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.
Rieckmann A; Hærskjold A; Benn CS; Aaby P; Lange T; Sørup S
Int J Epidemiol; 2019 Dec; 48(6):2026-2038. PubMed ID: 31062020
[TBL] [Abstract][Full Text] [Related]
23. Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom.
Andrews N; Stowe J; Wise L; Miller E
Vaccine; 2010 Oct; 28(44):7215-20. PubMed ID: 20800702
[TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
Pietrzyk JJ; Wysocki J; Pejcz J; Galaj A; Majda-Stanislawska E; Käyhty H; Thierry-Carstensen B; Jensen AM
Vaccine; 2008 Sep; 26(41):5296-303. PubMed ID: 18675870
[TBL] [Abstract][Full Text] [Related]
25. Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study.
Huang K; Tao S; Zhou X; Mo J; Zhu B; Shen P; Lin H; Arena PJ; He N
Vaccine; 2020 Apr; 38(18):3422-3428. PubMed ID: 32178909
[TBL] [Abstract][Full Text] [Related]
26. Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers.
Hansen J; Timbol J; Lewis N; Pool V; Decker MD; Greenberg DP; Klein NP
Vaccine; 2016 Jul; 34(35):4172-4179. PubMed ID: 27373595
[TBL] [Abstract][Full Text] [Related]
27. Seasonal variation in rates of emergency room visits and acute admissions following recommended infant vaccinations in Ontario, Canada: a self-controlled case series analysis.
Hawken S; Potter BK; Benchimol EI; Little J; Ducharme R; Wilson K
Vaccine; 2014 Dec; 32(52):7148-53. PubMed ID: 25446834
[TBL] [Abstract][Full Text] [Related]
28. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study.
Nelson JC; Yu O; Dominguez-Islas CP; Cook AJ; Peterson D; Greene SK; Yih WK; Daley MF; Jacobsen SJ; Klein NP; Weintraub ES; Broder KR; Jackson LA
Am J Epidemiol; 2013 Jan; 177(2):131-41. PubMed ID: 23292957
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine.
Dutta AK; Verghese VP; Pemde HK; Mathew LG; Ortiz E
Indian Pediatr; 2009 Nov; 46(11):975-82. PubMed ID: 19955579
[TBL] [Abstract][Full Text] [Related]
30. Safety profile of
Puente Gómez I; Verheust C; Hanssens L; Dolhain J
Expert Rev Vaccines; 2020 Aug; 19(8):771-779. PubMed ID: 32729745
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when administered concurrently with a pneumococcal conjugate vaccine: a randomized, open-label, phase 3 study.
Bernstein HH; Noriega F;
Vaccine; 2011 Mar; 29(11):2212-21. PubMed ID: 20609398
[TBL] [Abstract][Full Text] [Related]
32. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
[TBL] [Abstract][Full Text] [Related]
34. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
35. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
Stein-Zamir C; Israeli A
Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial.
Langley JM; Halperin SA; Rubin E; White C; McNeil S; Mutch J; Mackinnon-Cameron D; Smith B
Pediatr Infect Dis J; 2012 Feb; 31(2):189-92. PubMed ID: 22173143
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and reactogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus and Haemophilus influenzae type B.
Shao PL; Lu CY; Hsieh YC; ; Bock HL; Huang LM
J Formos Med Assoc; 2011 May; 110(5):336-41. PubMed ID: 21621155
[TBL] [Abstract][Full Text] [Related]
38. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.
Daley MF; Yih WK; Glanz JM; Hambidge SJ; Narwaney KJ; Yin R; Li L; Nelson JC; Nordin JD; Klein NP; Jacobsen SJ; Weintraub E
Vaccine; 2014 May; 32(25):3019-24. PubMed ID: 24699471
[TBL] [Abstract][Full Text] [Related]
39. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
40. Reduced rate of side effects associated with separate administration of MMR and DTaP-Hib-IPV vaccinations.
Shneyer E; Strulov A; Rosenfeld Y
Isr Med Assoc J; 2009 Dec; 11(12):735-8. PubMed ID: 20166340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
